REG - State Of Israel - Publication of Suppl.Prospcts

National Storage REITAnnouncement

04/01/2019 13:30

RNS Number : 2589M
State Of Israel
04 January 2019
 


 
State of Israel-Ministry of Finance
 
Publication of Supplement to the Base Prospectus
 
The following supplement (the "Supplement") to the base prospectus (the "Base Prospectus") has been approved by the UK Listing Authority and is available for viewing:
 
Supplement dated 4 January 2019 to the Base Prospectus dated 9 August 2018 relating to the State of Israel €10,000,000,000 Euro Medium Term Note Programme
 
Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.
 
To view the full document, and each document incorporated by reference, please paste the following URL into the address bar of your browser.
 
Supplement dated 4 January 2019 to the Base Prospectus dated 9 August 2018
 
http://www.rns-pdf.londonstockexchange.com/rns/2589M_1-2019-1-4.pdf
 
Amendment No. 1 to the Issuer's Annual Report on Form 18-K to the United States Securities and Exchange Commission for the fiscal year ended 31 December 2017, dated as of 3 January 2019
 
http://www.rns-pdf.londonstockexchange.com/rns/2589M_2-2019-1-4.pdf

 
The Issuer's Annual Report No. 16 of the Government Debt Management Unit in the Accountant General Division, for the year 2017


http://www.rns-pdf.londonstockexchange.com/rns/2589M_3-2019-1-4.pdf
 
A copy of the Supplement will be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.
 
DISCLAIMER - INTENDED ADDRESSEES
 
This announcement is not for distribution in the United States.
 
Please note that the information contained in the Base Prospectus as supplemented by the Supplement (together, the "Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.
 
In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.
 
The securities described in the Prospectus (the "Securities") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Securities may not be offered or sold directly or indirectly within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Prospectus in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the Securities in the United States.
 
For further information, please contact
 
Ministry of Finance of Israel
 
1 Kaplan St.
Hakiria
Jerusalem 91131
Israel
 
Telephone: +972-2-5317536
 
Fax: +972-2-5695387
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPLLFFFLVISIIA